Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,190 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Kettering OH, Springfield OH, Marysville OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase 2, Recruiting

Multi-Institutional Registry for Prostate Cancer Radiosurgery

for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Kettering OH, Lexington KY, Huntington WV, Elmhurst IL,
Sponsor: RPCR, Inc.

Sex: Male

Age: 18 - 70+

Code: NCT01226004

Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Kettering OH, Centerville OH, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Kettering OH, Cincinnati OH, Columbus OH, Louisville KY,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Kettering OH, Dublin OH, Hilliard OH, Columbus OH,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC

for
Functional Constipation (FC)
Location: Dayton OH, Smithfield PA, Kingwood WV, Scottdale PA,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 6 - 17

Code: NCT07723924

Phase 2, Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for
Pneumococcal Disease
Location: Dayton OH, Cincinnati OH, Allen Park MI,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07629440

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Dayton OH, Dearborn MI, Chicago IL, Palos Heights IL,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for
Pneumococcal Disease
Location: Dayton OH, Cincinnati OH, Bardstown KY, South Euclid OH,
Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase 3, Recruiting

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

for
Psychosis Associated With Alzheimer's Disease
Location: Dayton OH, Independence OH, London, Toronto,
Sponsor: MapLight Therapeutics

Sex: All

Age: 55 - 70+

Code: NCT06887192

Phase 2, Recruiting

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Kettering OH, Greenville SC, Norfolk VA, Yakima WA,
Sponsor: Cylene Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01199718

Phase 1, Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Dayton OH, Cincinnati OH, Indianapolis IN, Cleveland OH,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase 3, Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Beavercreek OH, Columbus OH, Mentor OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Beavercreek OH, Dayton OH, Southgate MI,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

for
Complex Regional Pain Syndrome Type I
Location: Dayton OH, Cleveland OH, Orland Park IL,
Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07210515

Phase 3, Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Kettering OH, Indianapolis IN, Cleveland OH,
Sponsor: SOFIE

Sex: All

Age: 18+

Code: NCT07217717

Phase 3, Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

for
Esophageal Cancer, Gastric Cancer (GC),
Location: Kettering OH, Indianapolis IN, Cleveland OH,
Sponsor: SOFIE

Sex: All

Age: 18+

Code: NCT07217704

Phase 3, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Centerville OH, Cincinnati OH, Columbus OH, Avon IN,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

for
Ulcerative Colitis (UC)
Location: Beavercreek OH, Louisville KY, London, Scarborough,
Sponsor: Xencor, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06619990

Phase 1, Phase 2, Recruiting

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Dayton OH, Columbus OH, Delaware OH, Marion OH,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase 2, Recruiting